Skip to main content
logo
Regen BioPharma, Inc. (RGBP)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 29, 2026, 10:17 AM EST

Regen BioPharma Financials Overview

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Revenue
0.240.240.240.240.240.17
Revenue Growth
0%0%0%0.44%37.57%55.63%
Gross Profit
0.240.240.240.240.240.17
Operating Income
-0.87-0.34-0.42-0.69-0.34-0.2
Net Income
-0.72-1.27-0.671.022.23-6.77
Earnings Per Share
-0.01-0.05-0.080.140.36-1.68
EPS Growth
----59.25%--

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash & Investments
00.0700.120.050.73
Total Debt
0.961.20.790.761.273.58
Net Cash (Debt)
-0.96-1.13-0.79-0.64-1.22-2.86
Net Cash Growth
------
Net Cash Per Share
-0.01-0.05-0.10-0.09-0.19-0.71

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Operating Cash Flow
-0.48-0.38-0.75-0.17-0.61-1.13
Free Cash Flow
-0.48-0.38-0.75-0.17-0.61-1.13
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-367.41%-143.11%-176.37%-290.39%-144.20%-117.28%
Pretax Margin
-302.54%-538.76%-282.49%488.89%1037.52%-3951.79%
Profit Margin
-302.54%-538.76%-282.49%432.66%945.59%-3951.79%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PE Ratio
---6.1814.69-
PS Ratio
0.242.254.3526.75138.87760.54